[The biological half-life of plasmin-treated human immunoglobulin in blood (author's transl)]. 1980

H Kaneko, and T Shirai, and M Yamauchi, and M Umeda, and T Tsukahara, and K Maki, and S Watanabe, and T Hirahara, and I Ishikawa, and Y Kiga, and Y Takatsuki, and M Kato

UI MeSH Term Description Entries
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005341 Fibrinolysin A product of the lysis of plasminogen (profibrinolysin) by PLASMINOGEN activators. It is composed of two polypeptide chains, light (B) and heavy (A), with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins. Plasmin,Fibrogammin,Glu-Plasmin,Protease F,Thrombolysin,Glu Plasmin
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

H Kaneko, and T Shirai, and M Yamauchi, and M Umeda, and T Tsukahara, and K Maki, and S Watanabe, and T Hirahara, and I Ishikawa, and Y Kiga, and Y Takatsuki, and M Kato
May 1977, Deutsche medizinische Wochenschrift (1946),
H Kaneko, and T Shirai, and M Yamauchi, and M Umeda, and T Tsukahara, and K Maki, and S Watanabe, and T Hirahara, and I Ishikawa, and Y Kiga, and Y Takatsuki, and M Kato
June 1965, Journal of pharmaceutical sciences,
H Kaneko, and T Shirai, and M Yamauchi, and M Umeda, and T Tsukahara, and K Maki, and S Watanabe, and T Hirahara, and I Ishikawa, and Y Kiga, and Y Takatsuki, and M Kato
June 1978, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
H Kaneko, and T Shirai, and M Yamauchi, and M Umeda, and T Tsukahara, and K Maki, and S Watanabe, and T Hirahara, and I Ishikawa, and Y Kiga, and Y Takatsuki, and M Kato
December 1980, Aktuelle Gerontologie,
H Kaneko, and T Shirai, and M Yamauchi, and M Umeda, and T Tsukahara, and K Maki, and S Watanabe, and T Hirahara, and I Ishikawa, and Y Kiga, and Y Takatsuki, and M Kato
January 1978, International archives of allergy and applied immunology,
H Kaneko, and T Shirai, and M Yamauchi, and M Umeda, and T Tsukahara, and K Maki, and S Watanabe, and T Hirahara, and I Ishikawa, and Y Kiga, and Y Takatsuki, and M Kato
October 1971, Klinische Wochenschrift,
H Kaneko, and T Shirai, and M Yamauchi, and M Umeda, and T Tsukahara, and K Maki, and S Watanabe, and T Hirahara, and I Ishikawa, and Y Kiga, and Y Takatsuki, and M Kato
January 1982, Vox sanguinis,
H Kaneko, and T Shirai, and M Yamauchi, and M Umeda, and T Tsukahara, and K Maki, and S Watanabe, and T Hirahara, and I Ishikawa, and Y Kiga, and Y Takatsuki, and M Kato
January 1974, [Hokkaido igaku zasshi] The Hokkaido journal of medical science,
H Kaneko, and T Shirai, and M Yamauchi, and M Umeda, and T Tsukahara, and K Maki, and S Watanabe, and T Hirahara, and I Ishikawa, and Y Kiga, and Y Takatsuki, and M Kato
January 1980, Allergie und Immunologie,
H Kaneko, and T Shirai, and M Yamauchi, and M Umeda, and T Tsukahara, and K Maki, and S Watanabe, and T Hirahara, and I Ishikawa, and Y Kiga, and Y Takatsuki, and M Kato
January 1982, Arzneimittel-Forschung,
Copied contents to your clipboard!